NVCT logo

NVCTNuvectis Pharma Inc

$9.80
$0.38
(4.03%)
Today
Closed $9.80
$0.00
(0.00%)
After Hours
Updated: 04:10 PM EDT
EarningsAug 4
Mkt Cap$249.87M
Vol64,124.00
News
all
press releases
Wall Street Analysts Think Nuvectis Pharma (NVCT) Could Surge 57%: Read This Before Placing a Bet
The mean of analysts' price targets for Nuvectis Pharma (NVCT) points to a 57% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks
News Placeholder
More News
News Placeholder
Wall Street Analysts Believe Nuvectis Pharma (NVCT) Could Rally 62.5%: Here's is How to Trade
The average of price targets set by Wall Street analysts indicates a potential upside of 62.5% in Nuvectis Pharma (NVCT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Zacks
News Placeholder
Nuvectis Pharma (NASDAQ:NVCT) Releases Quarterly Earnings Results, Beats Estimates By $0.04 EPS
Nuvectis Pharma (NASDAQ:NVCT - Get Free Report) announced its quarterly earnings results on Tuesday. The company reported ($0.26) earnings per share for the quarter, topping the consensus estimate of ($0.30) by $0.04...
MarketBeat
News Placeholder
Nuvectis Pharma (NVCT) Projected to Post Earnings on Tuesday
Nuvectis Pharma (NASDAQ:NVCT) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 5. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-5-nuvectis-pharma-inc-stock...
MarketBeat
News Placeholder
Nuvectis Pharma, Inc. $NVCT Shares Acquired by Iridian Asset Management LLC CT
Iridian Asset Management LLC CT increased its holdings in Nuvectis Pharma, Inc. (NASDAQ:NVCT - Free Report) by 44.5% during the fourth quarter, according to its most recent filing with the Securities...
MarketBeat
News Placeholder
Nuvectis Pharma (NASDAQ:NVCT) Trading Down 1.7% - Here's What Happened
Nuvectis Pharma (NASDAQ:NVCT) Shares Down 1.7% - What's Next...
MarketBeat
News Placeholder
Nuvectis Pharma (NASDAQ:NVCT) Shares Up 6.3% - Still a Buy?
Nuvectis Pharma (NASDAQ:NVCT) Shares Up 6.3% - Still a Buy...
MarketBeat
News Placeholder
Nuvectis Pharma (NVCT) to Release Quarterly Earnings on Tuesday
Nuvectis Pharma (NASDAQ:NVCT) will be releasing its Q4 2025 earnings before the market opens on Tuesday, February 24. (View Earnings Report at...
MarketBeat
News Placeholder
HC Wainwright Forecasts Weaker Earnings for Nuvectis Pharma
Nuvectis Pharma, Inc. (NASDAQ:NVCT - Free Report) - Stock analysts at HC Wainwright reduced their FY2026 earnings estimates for Nuvectis Pharma in a research report issued on Wednesday, February...
MarketBeat
News Placeholder
HC Wainwright Predicts Nuvectis Pharma Q1 Earnings
Nuvectis Pharma, Inc. (NASDAQ:NVCT - Free Report) - Research analysts at HC Wainwright issued their Q1 2026 EPS estimates for Nuvectis Pharma in a research note issued on Wednesday, February 11th. HC...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.